CSL Company

CSL develops innovative biotherapies and influenza vaccines that save lives, and help people with life-threatening medical conditions.

Invests into

Technology: Image-Based & Radiology Diagnostics
Industry: Deep Diagnostics
Headquarters: Parkville, New South Wales, Australia
Founded Date: 01.01.1916
Employees Number: 10001+
Funding Status: M&A
Estimated Revenue: $1B to $10B
Last Funding Date: 2004-02-06
Last Funding Type: Post-IPO Equity

Visit Website
web.queries@computershare.com.au
https://twitter.com/csl
Register and Claim Ownership